Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-560.21M
↓ 113% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-262.48M
Historical baseline
PeriodValueYoY Change
TTM$-560.21M-31.3%
2024$-426.72M-38.7%
2023$-307.63M-35.1%
2022$-227.66M-30.0%
2021$-175.12M-114.3%
2020$-81.70M-40.1%
2019$-58.34M-